Development of transcriptomic biomarker signature in human saliva to detect lung cancer
暂无分享,去创建一个
D. Chia | N. Park | Lei Zhang | Hua Xiao | Hui Zhou | D. Elashoff | David Akin | Xinmin Yan | D. Wong | E. Garon | O. Brinkmann | Jay M. Lee | Silverio M. Santiago | Jieping Yang
[1] Lei Zhang,et al. Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[2] Peter Beyerlein,et al. Diagnostic potential of saliva: current state and future applications. , 2011, Clinical chemistry.
[3] Paul F. Pinsky,et al. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. , 2011, Radiology.
[4] Hua Xiao,et al. Proteomics and its applications for biomarker discovery in human saliva , 2011, Bioinformation.
[5] W. Pang,et al. Proteomic Analysis of Whole Human Saliva Detects Enhanced Expression of Interleukin-1 Receptor Antagonist, Thioredoxin and Lipocalin-1 in Cigarette Smokers Compared to Non-Smokers , 2010, International journal of molecular sciences.
[6] U. Sack,et al. Angiogenic markers in breath condensate identify non-small cell lung cancer. , 2010, Lung cancer.
[7] David Elashoff,et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. , 2010, Gastroenterology.
[8] D. Porteous,et al. Sputum trace metals are biomarkers of inflammatory and suppurative lung disease. , 2010, Chest.
[9] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[10] C. Pirker,et al. EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases , 2009, Clinical Cancer Research.
[11] David Elashoff,et al. Electrochemical Sensor for Multiplex Biomarkers Detection , 2009, Clinical Cancer Research.
[12] G. Eibl,et al. Systemic Disease-Induced Salivary Biomarker Profiles in Mouse Models of Melanoma and Non-Small Cell Lung Cancer , 2009, PloS one.
[13] N. Gotoh,et al. The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment , 2009, Expert opinion on therapeutic targets.
[14] R. Crystal,et al. Cigarette smoking induces overexpression of a fat-depleting gene AZGP1 in the human. , 2009, Chest.
[15] John R Yates,et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). , 2009, Journal of proteome research.
[16] T. Church,et al. A Prospectively Measured Serum Biomarker for a Tobacco-Specific Carcinogen and Lung Cancer in Smokers , 2009, Cancer Epidemiology Biomarkers & Prevention.
[17] N. Viñolas,et al. Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE , 2008, Tumor Biology.
[18] Holly Janes,et al. Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design , 2008, Journal of the National Cancer Institute.
[19] David Elashoff,et al. Salivary Proteomics for Oral Cancer Biomarker Discovery , 2008, Clinical Cancer Research.
[20] David Elashoff,et al. Exon-level expression profiling: a comprehensive transcriptome analysis of oral fluids. , 2008, Clinical chemistry.
[21] R. Carano,et al. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models , 2008, Oncogene.
[22] A. Vissink,et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. , 2007, Arthritis and rheumatism.
[23] S. Hirohashi,et al. Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma , 2007, Cancer science.
[24] P. Sebastiani,et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer , 2007, Nature Medicine.
[25] Ron Edgar,et al. NCBI GEO standards and services for microarray data , 2006, Nature Biotechnology.
[26] Anil Potti,et al. Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors , 2006, BMC Genomics.
[27] N. Park,et al. Characterization of RNA in Saliva , 2006, Clinical chemistry.
[28] T. Byers,et al. Lack of Association between Sputum Atypia and Chronic Obstructive Pulmonary Disease Mortality , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[29] D. Wong,et al. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. , 2006, Journal of the American Dental Association.
[30] David Shitrit,et al. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature. , 2005, The oncologist.
[31] M. Posner,et al. The salivary microbiota as a diagnostic indicator of oral cancer: A descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects , 2005, Journal of Translational Medicine.
[32] M. Meyerson,et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. , 2005, The New England journal of medicine.
[33] L. Mariani,et al. Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer. , 2005, Cancer research.
[34] K. Jirström,et al. Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression , 2005, Breast Cancer Research and Treatment.
[35] David Elashoff,et al. Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.
[36] Daniel A. Haber,et al. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways , 2004, Science.
[37] Gang Liu,et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[38] S. Gabriel,et al. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.
[39] N. Viñolas,et al. Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis , 2003, Tumor Biology.
[40] Stephen S Hecht,et al. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. , 2002, The Lancet. Oncology.
[41] M. von Knebel Doeberitz,et al. Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP‐specific RT‐PCR , 2001, International journal of cancer.
[42] T. Petty. The early identification of lung carcinoma by sputum cytology , 2000, Cancer.
[43] R. Weigel,et al. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. , 2000, Cancer research.
[44] J. Jen,et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.
[45] L. Tanoue,et al. Molecular Origins of Cancer. Lung Cancer , 2010 .
[46] Lei Zhang,et al. Salivary biomarkers for clinical applications. , 2009, Molecular diagnosis & therapy.
[47] Philip Smith,et al. Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.
[48] Terry M. Therneau,et al. What Does PLIER Really Do? , 2008, Cancer informatics.
[49] David Spizarny,et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. , 2005, Lung cancer.
[50] D. Wong,et al. RNA Profiling of Cell-free Saliva Using Microarray Technology , 2004, Journal of dental research.